Clonal Cytopenia of Undetermined Significance in a Patient with Congenital Wilms' Tumor 1 and Acquired DNMT3A Gene Mutations.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
01 Dec 2021
Historique:
pubmed: 1 6 2021
medline: 15 12 2021
entrez: 31 5 2021
Statut: ppublish

Résumé

Congenital mutations of the Wilms' tumor 1 (WT1) gene can lead to various abnormalities, including renal/gonadal developmental disorders and cardiac malformations. Although there have been many reports of somatic WT1 mutations in patients with acute myeloid leukemia and myelodysplastic syndrome, congenital WT1 mutations have not been reported in hematological disorders. We herein report a patient with early-onset clonal cytopenia of undetermined significance that was associated with a congenital mutation of WT1 and an acquired mutation of DNMT3A [encoding DNA (cytosine-5)-methyltransferase 3A].

Identifiants

pubmed: 34053991
doi: 10.2169/internalmedicine.7571-21
pmc: PMC8710374
doi:

Substances chimiques

DNMT3A protein, human 0
WT1 Proteins 0
DNA Methyltransferase 3A EC 2.1.1.37

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3785-3788

Références

Mol Cell. 2015 Feb 19;57(4):662-673
pubmed: 25601757
Cardiol Young. 2020 May;30(5):641-648
pubmed: 32248856
Cell Rep. 2014 Dec 11;9(5):1841-1855
pubmed: 25482556
J Clin Invest. 2017 Oct 2;127(10):3657-3674
pubmed: 28872462
Hum Mol Genet. 2013 Jan 1;22(1):74-83
pubmed: 23042785
FASEB J. 2008 Aug;22(8):2690-701
pubmed: 18424770
Blood. 2015 Nov 19;126(21):2355-61
pubmed: 26429975
Blood. 2018 Sep 20;132(12):1265-1278
pubmed: 30064973
J Cardiol. 2016 Sep;68(3):181-9
pubmed: 27134136
Blood. 2019 Mar 7;133(10):1049-1059
pubmed: 30670442
Blood. 2010 Jun 24;115(25):5222-31
pubmed: 20368469
Am J Hematol. 2016 Dec;91(12):1234-1238
pubmed: 27717004
N Engl J Med. 2014 Dec 25;371(26):2488-98
pubmed: 25426837
Nature. 2020 Oct;586(7831):763-768
pubmed: 33057201
Development. 2017 Aug 15;144(16):2862-2872
pubmed: 28811308
Am J Hum Genet. 1998 Apr;62(4):824-33
pubmed: 9529364
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Cell Stem Cell. 2018 Feb 1;22(2):157-170
pubmed: 29395053
Blood. 2017 Aug 10;130(6):753-762
pubmed: 28655780
EMBO J. 2001 Apr 17;20(8):1897-909
pubmed: 11296223

Auteurs

Ken Murakami (K)

Department of Hematology, Sumitomo Hospital, Japan.

Yuuta Yamaguchi (Y)

Department of Hematology, Sumitomo Hospital, Japan.

Yuko Kida (Y)

Department of Hematology, Sumitomo Hospital, Japan.

Yoichiro Morikawa (Y)

Department of Hematology, Sumitomo Hospital, Japan.

Hidetoshi Ujiie (H)

Department of Hematology, Sumitomo Hospital, Japan.

Hiroyuki Sugahara (H)

Department of Hematology, Sumitomo Hospital, Japan.

Yasuhito Nannya (Y)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan.

Seishi Ogawa (S)

Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan.

Yuzuru Kanakura (Y)

Department of Hematology, Sumitomo Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH